BOC Sciences - Products
London
BOC Sciences provides various research (bio)chemicals: inhibitors, building blocks, carbohydrates, nucleosides, nucleotides, GMP Products, impurities, metabolites, APIs, natural compounds, ADCs, and chiral compounds.
| Product | Description | |
|---|---|---|
| Piperlotine D | Piperlotine D is isolated from the herbs of Piper nigrum L. Uses: Antiplatelet aggregation. Group: Pharmaceutical. CAS No. 958296-13-4. Pack Sizes: 1 mg. Product ID: NP0176. Molecular formula: Custom synthesis is available. Send your inquiries for more information. |  London |
| Piperoxane hydrochloride | Piperoxan is an antihistamine drug which is derived from benzodioxan. At first it was investigated by Fourneau as an α-adrenergic-blocking agent, then they found it resistant to histamine-induced bronchospasm in guinea pigs. Uses: Piperoxan is an antihistamine drug. Group: Pharmaceutical. CAS No. 135-87-5. Pack Sizes: 100 mg. Product ID: B0084-222886. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Pipotiazine Impurities | Pipotiazine Impurities, critical in the biomedical field, are predominantly used to assess the purity and efficacy of pipotiazine, a drug employed in managing schizophrenia and bipolar disorder. These impurities aid in ensuring therapeutic efficacy and safety, offering vital insights for drug development and quality control in psychiatric treatments. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Piracetam Impurities | Piracetam Impurities in the biomedical industry play a crucial role in quality control and research, ensuring the purity and efficacy of Piracetam, a nootropic drug. These impurities help in identifying degradation products and enhancing the understanding of the drug's safety and stability, ultimately aiding in the treatment of cognitive disorders and dementia. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Piragrel Impurities | Piragrel Impurities, integral components of biomedical scrutiny, are essential for evaluating the purity and biological efficacy of Piragrel, a thrombotic prevention agent in cardiovascular treatment. These impurities facilitate comprehensive insights into the drug's metabolism, safety, and therapeutic effectiveness, underpinning advancements in pharmacological development and clinical application. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Pirarubicin | Pirarubicin is an anthracycline antibiotic, and also a DNA/RNA synthesis inhibitor by intercalating into DNA and interacts with topoisomerase II, used as an antineoplastic agent. Group: Pharmaceutical. CAS No. 72496-41-4. Pack Sizes: 25 mg. Product ID: BBF-03937. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Pirenzepine hydrochloride | Pirenzepine hydrochloride is an antiulcerative that acts via suppressing gastric secretion. Pirenzepine is a selective muscarinic M1 receptor antagonist. Uses: M1 muscarinic receptor selective antagonist. Group: Pharmaceutical. CAS No. 29868-97-1. Pack Sizes: 5 g. Product ID: B0046-463922. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Pirfenidone | Pirfenidone is an inhibitor for TGF-β production and TGF-β stimulated collagen production, reduces production of TNF-α and IL-1β, and also has anti-fibrotic and anti-inflammatory properties. Group: Pharmaceutical. CAS No. 53179-13-8. Pack Sizes: 50 g. Product ID: NP3040. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Pirfenidone-[d5] | Pirfenidone-[d5] is the labelled analogue of Pirfenidone, which is an inhibitor for TGF-β production and TGF-β stimulated collagen production with anti-fibrotic and anti-inflammatory properties. Pirfenidone is a medication used for the treatment of idiopathic pulmonary fibrosis. Group: Pharmaceutical. CAS No. 1020719-62-3. Pack Sizes: 5 mg. Product ID: BLP-012523. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Pirfenidone Impurities | Pirfenidone impurities stand as vital reference materials within the biomedical sector, fundamentally instrumental for assessing the quality and potency of pirfenidone, an antifibrotic utilized in idiopathic pulmonary fibrosis management. These impurities are crucial in guaranteeing formulation purity, thereby reinforcing drug safety and adherence to regulatory standards. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Pirimicarb Impurities | Pirimicarb Impurities, integral to analytical research and stringent quality control sectors, play a crucial role in the synthesis of pirimicarb by elucidating its potential off-target neurological ramifications. Their study augments toxicological profiling, fostering safer pesticide formulations and novel therapeutic avenues for neurodegenerative diseases, thereby underpinning advancements in neuropharmacology. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Piroxicam-β-cyclodextrin | Piroxicam-β-cyclodextrin is a non-steroidal anti-inflammatory drug with anti-inflammatory, analgesic and antipyretic properties. Group: Pharmaceutical. CAS No. 96684-39-8. Pack Sizes: 1 kg. Product ID: B1999-046169. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Piroxicam Impurities | Piroxicam Impurities, present as chemical intermediates in drug synthesis, play a critical role in quality control and assurance processes for the anti-inflammatory medication Piroxicam. Their identification and analysis are vital for ensuring drug efficacy and safety, which is essential in treating conditions like rheumatoid arthritis and osteoarthritis. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Pirtobrutinib | Pirtobrutinib is a Bruton's tyrosine kinase (BTK) inhibitor and antineoplastic agent. Group: Pharmaceutical. CAS No. 2101700-15-4. Pack Sizes: 1 g. Product ID: B1370-372922. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Pisatin | Pisatin is a phenolic compound synthesized by pea. Pisatin was the first phytoalexin to be purified and chemically identified. Group: Pharmaceutical. CAS No. 20186-22-5. Pack Sizes: 1 mg. Product ID: NP4949. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Pitavastatin 5-Oxo Impurity Calcium Salt | An impurity in the synthesis of Pitavastatin, a HMG-CoA reductase inhibitor that lowers LDL cholesterol and triglycerides and increase HDL cholesterol in your blood. Group: Pharmaceutical. CAS No. 2180095-22-9. Pack Sizes: 5 mg. Product ID: B2694-008615. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Pitavastatin calcium | Pitavastatin calcium is a novel member of the medication class of statins. Group: Pharmaceutical. CAS No. 147526-32-7. Pack Sizes: 1 g. Product ID: NP3453. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Pitavastatin Impurities | Pitavastatin Impurities hold a paramount place in the biomedical field, underpinning meticulous quality assurance and safety evaluations of pitavastatin, an essential statin for hypercholesterolemia control. These impurities critically assess purity, efficacy, and potential adverse impacts, safeguarding the medication's prowess in cholesterol modulation and cardiovascular prophylaxis. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Pitavastatin Impurity 8 | An impurity of Pitavastatin which lowers both total cholesterol and low density lipoprotein cholesterol in animals and humans. Group: Pharmaceutical. CAS No. 1044518-75-3. Pack Sizes: 25 mg. Product ID: B2694-478922. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Pitavastatin Lactone | A metabolite of Pitavastatin which is a member of the blood cholesterol lowering medication class of statins. Uses: Hydroxymethylglutaryl-coa reductase inhibitors. Group: Pharmaceutical. CAS No. 141750-63-2. Pack Sizes: 50 mg. Product ID: B2694-058508. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Pixantrone Impurities | Pixantrone Impurities are meticulously scrutinized within the biomedical domain to ensure the purity and efficacy of treatments linked to pixantrone. Accurate identification of these impurities is crucial, particularly in therapies for non-Hodgkin lymphoma, meeting stringent regulatory standards and improving patient outcomes via advanced pharmaceutical formulations. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Pizotifen malate | Pizotifen is a benzocycloheptene-based drug used for the treatment of recurrent migraine headaches. It acts as an antagonist of 5-HT2A and 5HT2C receptors. Group: Pharmaceutical. CAS No. 5189-11-7. Pack Sizes: 2.5 g. Product ID: B0046-093556. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| PJ34 | PJ34 is a novel and potential PARP inhibitor with potential anticancer activity. PJ34 has a high affinity for PARP-1 (IC(50) = 20 nM). Group: Pharmaceutical. CAS No. 344458-15-7. Pack Sizes: 100 mg. Product ID: B2693-110378. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| PKC-Theta Inhibitor | PKC-theta inhibitor is a selective PKC-theta inhibitor with IC50 of 12 nM. Group: Pharmaceutical. CAS No. 736048-65-0. Pack Sizes: 5 mg. Product ID: B2693-373030. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| PKG Drug G1 | PKG drug G1 is an activator of protein kinase GIα (PKGIα). It induces vasodilation and blood pressure reduction through the C42 PKG Iα independent mechanism. Group: Pharmaceutical. CAS No. 374703-78-3. Pack Sizes: 100 mg. Product ID: B2693-373024. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| PKR-IN-1 | Activator of pyruvate kinase isoenzyme M2 (PKM2), an enzyme involved in glycolysis. Since all tumor cells exclusively express the embryonic M2 isoform of PK, it is hypothesized that PKM2 is a potential target for cancer therapy. Modulation of PKM2 might also be effective in the treatment of obesity, diabetes, autoimmune conditions, and antiproliferation-dependent diseases. Group: Pharmaceutical. CAS No. 1260075-17-9. Pack Sizes: 100 mg. Product ID: B0084-463157. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Pladienolide D | Pladienolide D is an antitumor macrolide produced by Streptomyces platensis. Group: Pharmaceutical. CAS No. 445487-91-2. Pack Sizes: 50 mg. Product ID: BBF-05912. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Plantainoside D | Plantainoside D is a natural compound of the sesquiterpenoid class. Group: Pharmaceutical. CAS No. 147331-98-4. Pack Sizes: 5 mg. Product ID: B0005-053418. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Platycodin D3 | Platycodin D3 has anti-hepatitis C virus (HCV) activity. It can be used as an expectorant in a variety of lung inflammatory diseases and regulate the production and secretion of mucin in the airway. Platycodin D3 is a triterpenoid compound and an inhibitor of NF-κB. Group: Pharmaceutical. CAS No. 67884-03-1. Pack Sizes: 5 mg. Product ID: B0005-053417. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Platycoside E | Platycoside E is a triterpenoid compound. Group: Pharmaceutical. CAS No. 237068-41-6. Pack Sizes: 5 mg. Product ID: B0005-053414. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Platycoside G1 | Platycoside G1 is a triterpenoid compound found in the roots of Platycodon grandiflorum. Group: Pharmaceutical. CAS No. 849758-42-5. Pack Sizes: 5 mg. Product ID: B0005-053401. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Plecanatide | Plecanatide, also called Trulance, a synthetic analogue of uroguanylin, is a guanylate cyclase-C (GCC) agonist being developed by Synergy Pharmaceuticals for the treatment of gastrointestinal disorders, such as chronic idiopathic constipation (CIC) and irritable bowel syndrome with constipation (IBS-C). In January 2017, an oral formulation of plecanatide received its first global approval in the USA for the treatment of adult patients with CIC. Besides, Plecanatide is undergoing phase III investigation in IBS-C. It had also undergone preclinical investigations in inflammatory bowel disease (IBD) and ulcerative colitis; however, development in these indications has been discontinued. Uses: Guanylyl cyclase c agonists; gastrointestinal agents. Group: Pharmaceutical. CAS No. 467426-54-6. Pack Sizes: 5 mg. Product ID: BAT-010091. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Pleconaril | Pleconaril is a capsid function inhibitor which targets a conserved hydrophobic pocket of a major viral capsid protein called VP-1. Pleconaril inhibits attachment and virus uncoating. Uses: Picornavirus replication inhibitor. antiviral. Group: Pharmaceutical. CAS No. 153168-05-9. Pack Sizes: 25 mg. Product ID: B0084-059600. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Plerixafor | Plerixafor is a chemokine receptor antagonist for CXCR4 and CXCL12-mediated chemotaxis with IC50 of 44 nM and 5.7 nM, respectively. Uses: Anti-hiv agents. Group: Pharmaceutical. CAS No. 110078-46-1. Pack Sizes: 25 mg. Product ID: B0084-054319. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Plerixafor Impurities | Plerixafor Impurities, essential in the biomedical realm, bolster stringent quality control in Plerixafor synthesis. This therapeutic agent is crucial for hematopoietic stem cell mobilization, particularly in non-Hodgkins lymphoma and multiple myeloma care. These impurities verify safety and potentiate efficacy, thus enhancing therapeutic reliability and clinical success. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Plerixafor Impurity I | An impurity of Plerixafor which is a chemokine receptor antagonist for CXCR4 and CXCL12-mediated chemotaxis with IC50 of 44 nM and 5.7 nM, respectively. Group: Pharmaceutical. CAS No. 176252-20-3. Pack Sizes: 10 mg. Product ID: B2694-478949. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Plerixafor Impurity III | Plerixafor Impurity III is an impurity of Plerixafor, an immunostimulant indicated in combination with G-CSF to mobilize hematopoietic stem cells to the peripheral blood for collection and subsequent autologous transplantation in patients with NHL and MM. Group: Pharmaceutical. CAS No. 771464-86-9. Pack Sizes: 5 mg. Product ID: B2694-341919. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Plicatol B | Plicatol B is a phenanthrene isolated from the stems of the orchid Flickingeria fimbriata. Group: Pharmaceutical. CAS No. 108335-06-4. Pack Sizes: 5 mg. Product ID: B0005-053399. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Plitidepsin | Plitidepsin is a cyclic depsipeptide isolated from the marine tunicate Aplidium albicans. Plitidepsin shows potent anticancer activity against a large variety of cultured human cancer cells, inducing apoptosis by triggering mitochondrial cytochrome c release, initiating the Fas/DC95, JNK pathway and activating caspase 3 activation. This agent also inhibits elongation factor 1-a, thereby interfering with protein synthesis, and induces G1 arrest and G2 blockade, thereby inhibiting tumor cell growth. Group: Pharmaceutical. CAS No. 137219-37-5. Pack Sizes: 1 mg. Product ID: BAT-010093. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Pluripotin | SC1 (Pluripotin) was identified in a cell-based chemical library screen for small molecules that regulate mouse embryonic stem (ES) cell self-renewal. SC1 is sufficient to sustain long-term self-renewal of mouse ES cells in an undifferentiated state in the absence of LIF, feeder cells, or serum. SC1 acts through dual inhibition of extracellular signal-regulated kinase 1 (ERK1) and Ras GTPase-activating protein (Ras-GAP). Mouse ES cells maintained in the presence of SC1 retain their ability to differentiate into cells representing all three germ layers in vitro, form chimeric mouse, and contribute to germ line in vivo. Uses: Self-renewal. Group: Pharmaceutical. CAS No. 839707-37-8. Pack Sizes: 100 mg. Product ID: B2693-462953. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| PLX51107 | PLX51107 is a potent and selective BET inhibitor with modest preference for bromodomain-1 (BD1) versus bromodomain-2 (BD2). It blocks the interaction mediated by the four BET family proteins. Group: Pharmaceutical. CAS No. 1627929-55-8. Pack Sizes: 50 mg. Product ID: B1370-291085. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| PLX5622 | PLX5622 is a highly selective and orally active CSF-1R inhibitor with IC50 < 10 nmol/L. Group: Pharmaceutical. CAS No. 1303420-67-8. Pack Sizes: 1 g. Product ID: B1370-059626. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| PLX-647 | PLX-647 is PLX647 is a potent inhibitors of both FMS and KIT that show strong selectivity compared with other kinases. In the in vitro enzymatic assay, PLX647 inhibits FMS with IC50 = 0.028μM and KIT with IC50 = 0.016 μM. PLX647 represents a unique class of kinase inhibitors with unique dual FMS and KIT specificity. Group: Pharmaceutical. CAS No. 873786-09-5. Pack Sizes: 50 mg. Product ID: B0084-462458. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| PMA | PMA, extracted from seeds of Euphorbia lathyris L, is a phorbol ester that is commonly used to activate certain types of protein kinase C (PKC), including group A (α, βI, βII, γ) and group B (δ, ε, η, θ) isoforms. It has been shown to inhibit apoptosis induced by the Fas antigen, but PMA induces apoptosis in HL-60 promyelocytic leukemia cells. Group: Pharmaceutical. CAS No. 16561-29-8. Pack Sizes: 25 mg. Product ID: B2703-350707. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| p-Menth-8-ene-1,2-diol | p-Menth-8-ene-1,2-diol is isolated from the herbs of Xanthium sibiricum. Group: Pharmaceutical. CAS No. 57457-97-3. Pack Sizes: 1 mg. Product ID: NP4546. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| p-Menthane-3,8-diol (Natural) | P-Menthane-3,8-diol, also called PARA-MENTHANE-3,8-DIOL, PMD, 1-(2-Hydroxy-4-methylcyclohexyl)-1-methylethanol,ect. Found in small quantities in the essential oil from the leaves of Corymbia citriodora, formerly known as Eucalyptus citriodora. It smells similar to menthol and has a cooling feel.Our product is from natural source. Uses: Insecticide; food additive; spice; cosmetics. Group: Pharmaceutical. CAS No. 42822-86-6. Pack Sizes: 25 g. Product ID: B0005-092293. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| PMPA sodium salt | PMPA is an inhibitor of glutamate carboxypeptidase 2 (GCP II/N-acetylated a-linked dipeptidase/NAALADase). Group: Pharmaceutical. CAS No. 373645-42-2. Pack Sizes: 50 mg. Product ID: B2693-342069. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| PMX 205 | PMX 205 is a potent C5a receptor peptide antagonist (IC50 = 31 nM). It is orally active and blocks inflammatory signaling and symptoms in animal models of colitis and allergic asthma. PMX 205 reduces fibrillar amyloid deposits, decreases hyperphosphorylated tau levels and rescues cognitive function in a mouse model of Alzheimer's Disease. Group: Pharmaceutical. CAS No. 514814-49-4. Pack Sizes: 10 mg. Product ID: BAT-010103. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| PMX 53 TFA | PMX 53 is a dual C5aR (CD88) antagonist and Mas-related gene 2 (MrgX2) agonist. It stimulates MrgX2-mediated mast cell degranulation, and also inhibits C5a-induced hypernociception in rats, inhibits lung metastasis in a mouse breast cancer model and reduces atherosclerotic lesions in a mouse model of atherosclerosis. Group: Pharmaceutical. CAS No. 852629-87-9. Pack Sizes: 5 mg. Product ID: BAT-016287. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| PNC-27 | PNC-27 is an anti-cancer peptide that induces tumor cell necrosis of a poorly differentiated non-solid tissue human leukemia cell line depending on expression of HDM-2 in the plasma membrane of these cells. Group: Pharmaceutical. Pack Sizes: 5 mg. Product ID: BAT-006241. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| PND-1186 (VS-4718) | PND-1186 (VS-4718) is a reversible and selective FAK inhibitor with IC50 of 1.5 nM. Phase 1. Group: Pharmaceutical. CAS No. 1061353-68-1. Pack Sizes: 50 mg. Product ID: B0084-463363. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Pneumocandin A0 | Pneumocandin A0 is a lipopeptide antibiotic produced by Zalerion arboricola. It has a strong anti-Candida effect. It has the effect of inhibiting the synthesis of 1,3 early-glucan in vitro, with an IC50 of 0.07-0.5 μg/mL. Pneumocandin A0 is an impurity of Micafungin. Group: Pharmaceutical. CAS No. 120692-19-5. Pack Sizes: 10 mg. Product ID: BBF-02575. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Pneumocandin B0 | Pneumocandin B0 is a lipopeptide antibiotic produced by Zalerion arboricola. It has a strong anti-Candida effect. It has the effect of inhibiting the synthesis of 1,3 early-glucan in vitro, with an IC50 of 0.07-0.5 μg/mL. Uses: Antifungal. Group: Pharmaceutical. CAS No. 135575-42-7. Pack Sizes: 100 mg. Product ID: BAT-010109. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Pneumocandin C0 | Pneumocandin C0 is a lipopeptide antibiotic produced by Zalerion arboricola. It has a strong anti-Candida effect. It has the effect of inhibiting the synthesis of 1,3 early-glucan in vitro, with an IC50 of 0.07-0.5 μg/mL. Pneumocandin C0 is an impurity of Caspofungin acetate which is an essential component of the cell wall of filamentous fungi. Group: Pharmaceutical. CAS No. 144074-96-4. Pack Sizes: 10 mg. Product ID: BBF-02577. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Pneumocandin Impurities | Pneumocandin Impurities, essential constituents in antifungal innovation, notably target Candida and Aspergillus species, underpinning development and optimization. These impurities serve as critical components in quality control and standardization, fortifying the efficacy and safety of echinocandin-class therapeutics designed to combat severe mycotic infections, thus enhancing clinical treatment reliability. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| p-Nitrophenyl 2-Acetamido-2-deoxy-α-D-galactopyranoside | p-Nitrophenyl 2-Acetamido-2-deoxy-α-D-galactopyranoside is an essential compound in biomedicine. It is commonly utilized in the production of synthetic substrates for studying glycosidase enzymes. This compound is valuable in research concerning carbohydrate chemistry, specifically in the investigation of enzymes involved in breaking down glycosylation processes. It plays a crucial role in medicinal chemistry by aiding in the development of drugs targeting certain diseases related to carbohydrate processing and glycosylation disorders. Group: Pharmaceutical. CAS No. 23646-68-6. Pack Sizes: 25 mg. Product ID: B1370-059264. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| p-[N-(p-Fluorophenyl)formimidoyl]phenol | An impurity of Febuxostat. Febuxostat is an antihyperuricemic nonpurine inhibitor of both the oxidized and reduced forms of xanthine oxidase. Group: Pharmaceutical. CAS No. 3382-63-6. Pack Sizes: 2 mg. Product ID: B2694-011490. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| PNU-101603 | Orally administered sutezolid is rapidly oxidized in vivo to an active sulfoxide metabolite (PNU-101603), which then undergoes renal excretion. Group: Pharmaceutical. CAS No. 168828-60-2. Pack Sizes: 1 mg. Product ID: B0084-007054. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| PNU-159682 | PNU-159682 is a major active metabolite of nemorubicin (MMDX) in human liver microsomes. It is a highly potent DNA topoisomerase II inhibitor with excellent cytotoxicity, and shows >3,000-fold cytotoxic than its parent compound (MMDX and doxorubicin). It is a more potent and well tolerated ADC cytotoxin than doxorubicin. Uses: Adcs cytotoxin. Group: Pharmaceutical. CAS No. 202350-68-3. Pack Sizes: 5 mg. Product ID: BBF-05916. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| PNU159682-EDA | PNU159682-EDA is a drug-linker conjugate for ADC by using PNU159682 (a potent DNA topoisomerase II inhibitor), linked via EDA. Group: Pharmaceutical. CAS No. 2255344-14-8. Pack Sizes: 5 mg. Product ID: BADC-01404. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| PNU-282987 hydrochloride | PNU-282987 is a highly selective α7 nAChR agonist (Ki = 26 nM) displaying negligible blockade of α1β1γδ and α3β4 nAChRs (IC50 ≥ 60 μM). Found to be inactive against a panel of 32 receptors at 1 μM, except 5-HT3 receptors (Ki = 930 nM). Group: Pharmaceutical. CAS No. 123464-89-1. Pack Sizes: 100 mg. Product ID: B0084-209211. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Podophyllotoxin Impurities | Podophyllotoxin Impurities are valuable reference materials in cancer research, particularly in developing chemotherapeutic agents like etoposide and teniposide. These impurities aid in understanding the purity and efficacy of podophyllotoxin-derived drugs, contributing to improved treatment regimens for various cancers, including testicular and lung cancer. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Pogostone | Pogostone, isolated from the herbs of Pogostemon cablin (Blanco) Benth, possesses potent anti-bacterial and anti-fungal activities and has been used for the quality control of essential oil of Pogostemon cablin. It could inhibit both gram negative bacteria (0.098-1 600 μg/ml) and gram positive bacteria (0.098-800 μg/ml). Besides, Pogostone could exert a gastro-protective effect against gastric ulceration, and the underlying mechanism might be associated with the stimulation of PGE2, improvement of antioxidant and anti-inflammatory status, as well as preservation of NP-SH. Pogostone exhibited an immunosuppressive property by directly blocking T cell proliferation as well as altering inflammatory cytokine profile. Uses: Anti-bacterial/anti-fungal. Group: Pharmaceutical. CAS No. 23800-56-8. Pack Sizes: 100 mg. Product ID: NP4575. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Policosanol | Policosanol is a mixture of long-chain alcohols found in plant waxes. Policosanol supplement is used as a lipid-lowering agent and potential hypotensive agent. Nutritional supplement in health care products. Uses: Ingredient of health care products. Group: Pharmaceutical. CAS No. 142583-61-7. Pack Sizes: 10 g. Product ID: B0005-166125. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Policresulen Impurities | Policresulen Impurities constitute a critical component in the analytical assessment of purity, safety, and therapeutic efficacy of the drug policresulen. Primarily targeting gynecological infections such as cervicitis and vaginitis, detecting these impurities ensures unwavering pharmaceutical quality and adherence to regulatory mandates in the realm of biomedical research and development. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Polmacoxib | Polmacoxib is a first-in-class NSAID drug candidate that acts as a dual inhibitor of COX-2 and carbonic anhydrase (CA). It exhibits superior safety for cardiovascular, renal, and gastrointestinal tissues due to its dual COX-2 and CA binding properties. Polmacoxib inhibits premalignant and malignant colorectal lesions in mouse models, partly through inhibiting tumor cell proliferation. Group: Pharmaceutical. CAS No. 301692-76-2. Pack Sizes: 10 mg. Product ID: B0084-462767. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Polyadenosinic acid potassium salt | Commonly used for DNA/RNA extraction. Group: Pharmaceutical. CAS No. 26763-19-9. Pack Sizes: 1 g. Product ID: B2699-177484. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| polydeoxyadenylic acid sodium salt | polydeoxyadenylic acid sodium salt. Group: Pharmaceutical. CAS No. 85578-95-6. Pack Sizes: 1 g. Product ID: B1370-139259. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Poly(D,L-lactide-co-glycolide) | Poly(D,L-lactide-co-glycolide) is used for macromolecular therapeutic delivery. Biodegradable and biocompatible poly(DL-lactide-co-glycolide) microspheres as an adjuvant for staphylococcal enterotoxin B toxoid can enhance the level of toxin-neutralizing antibodies. Group: Pharmaceutical. CAS No. 26780-50-7. Pack Sizes: 10 g. Product ID: B2697-011136. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Polyethylene glycol | Polyethylene glycol is a water-soluble, low immunogenic and biocompatible polymer formed by repeating units of ethylene glycol. Group: Pharmaceutical. CAS No. 25322-68-3. Pack Sizes: 1 kg. Product ID: B1370-088594. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
Would you like to list your products on UK Chemical Suppliers?
Our database is helping our users find suppliers everyday.